Skip to main content

Table 2 Serum biochemistry profile of the study patients

From: Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting

 

Non-Diabetic (n = 2181)

Good-control DM (n = 291)

Poor-control DM (n = 412)

P-value*

P-value†

P-value‡

LDL-C (mmol/l)

2.52 ± 1.02

2.43 ± 0.92

2.51 ± 1.15

0.12

0.80

0.33

HDL-C (mmol/l)

1.05 ± 0.28

1.05 ± 0.28

1.08 ± 0.56

0.95

0.27

0.36

TCH (mmol/l)

4.38 ± 1.18

4.28 ± 1.16

4.50 ± 1.35

0.17

0.10

0.02

TG (mmol/l)

1.90 ± 1.10

1.93 ± 1.09

2.15 ± 1.17

0.68

<0.0001

0.01

FPG (mmol/l)

5.34 ± 0.68

7.07 ± 2.14

10.19 ± 3.89

<0.0001

< 0.0001

< 0.0001

Mean HbA1c (%)

-

6.6 ± 0.7

8.8 ± 1.3

–

–

< 0.0001

Cr (μmol/l)

100.8 ± 27.6

101.3 ± 60.8

99.8 ± 32.5

0.88

0.58

0.68

  1. Data are presented as mean ± SD.
  2. * Non-diabetic patients versus good-control (diabetic patients with HbA1c ≤ 7%).
  3. † Non-diabetic patients versus poor-control (diabetic patients with HbA1c > 7%).
  4. ‡ Good-control versus poor-control diabetic patients.
  5. FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TCH, total cholesterol; TG, triglycerides; Cr, creatinine.